Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study

DSpace Repository

Show simple item record

dc.contributor.author Weide, Benjamin Matthias
dc.contributor.author Martens, Alexander
dc.contributor.author Wistuba-Hamprecht, Kilian
dc.contributor.author Zelba, Henning
dc.contributor.author Lipp, Hans-Peter
dc.contributor.author Soffel, Daniel
dc.contributor.author Garbe, Claus
dc.contributor.author Klumpp, Bernhard
dc.contributor.author Eigentler, Thomas Kurt
dc.date.accessioned 2017-12-11T16:06:29Z
dc.date.available 2017-12-11T16:06:29Z
dc.date.issued 2017
dc.identifier.issn 1432-0851
dc.identifier.uri http://hdl.handle.net/10900/79197
dc.language.iso en en
dc.publisher Springer de_DE
dc.relation.uri http://dx.doi.org/10.1007/s00262-016-1944-0 de_DE
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 610 de_DE
dc.subject.ddc 570 de_DE
dc.title Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study de_DE
dc.type Artikel de_DE
utue.quellen.id 20170815222223_01258
utue.publikation.seiten 441-449 de_DE
utue.personen.roh Weide, Benjamin
utue.personen.roh Martens, Alexander
utue.personen.roh Wistuba-Hamprecht, Kilian
utue.personen.roh Zelba, Henning
utue.personen.roh Maier, Ludwig
utue.personen.roh Lipp, Hans-Peter
utue.personen.roh Klumpp, Bernhard D.
utue.personen.roh Soffel, Daniel
utue.personen.roh Eigentler, Thomas K.
utue.personen.roh Garbe, Claus
dcterms.isPartOf.ZSTitelID Cancer Immunology Immunotherapy de_DE
dcterms.isPartOf.ZS-Issue 4 de_DE
dcterms.isPartOf.ZS-Volume 66 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record